scispace - formally typeset
C

Christopher J. Yuskaitis

Researcher at Boston Children's Hospital

Publications -  43
Citations -  3427

Christopher J. Yuskaitis is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Epilepsy. The author has an hindex of 14, co-authored 32 publications receiving 2944 citations. Previous affiliations of Christopher J. Yuskaitis include University of Alabama at Birmingham & Harvard University.

Papers
More filters
Journal ArticleDOI

De novo mutations in epileptic encephalopathies

Andrew S. Allen, +72 more
- 12 Sep 2013 - 
TL;DR: In this paper, a screen for de novo mutations in patients with two classical epileptic encephalopathies: infantile spasms and Lennox-Gastaut syndrome (n = 115) was performed.
Journal ArticleDOI

Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

TL;DR: GSK3 may contribute not only to primary pathologies in these diseases, but also to the associated inflammation, suggesting that GSK3 inhibitors may have multiple effects influencing these conditions.
Journal ArticleDOI

Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.

TL;DR: It is demonstrated that GSK3 promotes microglial responses to inflammation and that the utilization of G SK3 inhibitors provides a means to limit the inflammatory actions of microglia.
Journal ArticleDOI

GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism

TL;DR: It is indicated that impaired inhibitory regulation of GSK3 in Fmr1 knockout mice may contribute to some socialization deficits and that lithium treatment can ameliorate certain socialization impairments.
Journal ArticleDOI

Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome

TL;DR: Inhibitory serine-phosphorylation of GSK3 was lower in Fmr1 knockout, than wild-type, mouse brain regions and was increased by acute or chronic lithium treatment, which also increased hippocampal brain-derived neurotrophic factor levels.